Dagmar Bartášková

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin

Juan P. Frías, Alan Wynne, Beata Matyjaszek‐Matuszek et al. · Diabetes Obesity and Metabolism · 2019 · 43 citations

Improved Glycemic Control through Continuous Glucose Sensor-Augmented Insulin Pump Therapy: Prospective Results from a Community and Academic Practice Patient Registry

Ohad Cohen, Anna Körner, Rudolf Chlup et al. · Journal of Diabetes Science and Technology · 2009 · 25 citations · Full text

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna et al. · American Journal of Kidney Diseases · 2023 · 25 citations · Full text

Metabolic Syndrome, Hypertension, Urology +10